Revolutionary Bedside Cardiac Care for Newborns
World-renowned for its advancements in heart treatment, Nicklaus Children's Heart Institute introduces a groundbreaking procedure known as bedside transcatheter patent ductus arteriosus (PDA) closure, tailored specifically for newborns. This innovative capability brings state-of-the-art cardiac care right to the neonatal intensive care unit (NICU), a significant leap for medical practice aimed at improving health outcomes for fragile premature infants.
The Importance of Addressing PDA
In many newborns, particularly preterm infants, a crucial blood vessel called the patent ductus arteriosus remains open post-birth. Typically, this blood vessel should close shortly after birth, but when it doesn't, it can cause serious health issues. An open PDA can lead to increased blood flow to the lungs, resulting in breathing difficulties, feeding challenges, and growth delays. If medication fails to remediate the situation, a closure becomes vital to stabilize the baby's health.
Performing Procedures in the NICU
The innovative bedside technique enables clinicians to perform the PDA closure procedure safely in the infant's own environment, their isolette or crib. This alleviates the need for transporting these delicate patients to a separate catheterization lab, thus minimizing potential transport-related risks. By having a specialized catheterization team come to the NICU, we ensure that infants receive top-notch medical care right where they feel most secure.
Expert Leadership in Cardiac Innovation
The pioneer of this minimally invasive technique is Dr. Shyam Sathanandam, the newly appointed chief of cardiovascular medicine and co-director of the Nicklaus Children’s Heart Institute. His leadership is driving the institute to become a national leader in bedside PDA closure programs. From his strong commitment to child health, families can find reassurance in knowing their fragile newborns will not be transferred out of the NICU for necessary procedures.
Benefits of Bedside Procedures
Among the many advantages of bedside PDA closures is the reduction in the need for transporting fragile infants. This method not only minimizes the risks associated with movement but also adopts a minimally invasive approach, eliminating the need for a chest incision. The collaborative efforts of a dedicated clinical team, including neonatologists, cardiologists, and anesthesiologists, ensure swift and effective recovery for each infant.
Comprehensive Care for Every Infant
At Nicklaus Children's Heart Institute, not every PDA necessitates closure. A careful evaluation by a multidisciplinary team ensures that treatment is tailored to the unique needs of each infant. Whether that involves observation, medication, or closure, families are engaged at every step of care.
This new bedside PDA closure initiative expands the comprehensive pediatric cardiac programs already offered by Nicklaus Children's, providing families access to advanced therapeutic options right in their community. This alleviates the stress of families needing travel further for specialized care.
Recognized Excellence in Pediatric Cardiology
The Nicklaus Children's Heart Institute stands out internationally for its expertise in pediatric cardiology and cardiac surgery, successfully caring for numerous children with congenital and acquired heart diseases every year. The institute’s Pediatric and Congenital Catheterization Program is lauded as a global leader, employing cutting-edge technological innovations to execute a wide range of procedures, significantly reducing the need for more invasive surgeries.
Parents can rest assured knowing that the Nicklaus Children’s Heart Institute not only provides specialized cardiac care but is also built on a foundation of excellence supported by research and a robust network of pediatric specialties. As part of their mission to ensure that every child's health matters, they have established numerous outpatient care locations designed to extend their high-standard healthcare services across various communities.
Frequently Asked Questions
What is PDA, and why is its closure important?
Patent ductus arteriosus (PDA) is a condition where a blood vessel stays open after birth, potentially causing serious health complications for premature infants. Closure is important to stabilize their health.
Who leads the transcatheter PDA closure program?
The program is led by Dr. Shyam Sathanandam, the chief of cardiovascular medicine at Nicklaus Children's Heart Institute, who advocates for innovative and effective cardiac treatments for newborns.
What are the benefits of the bedside procedure?
The bedside PDA closure procedure reduces the need for patient transportation, minimizes risks, and allows for swift recovery through a collaborative medical team.
How is treatment determined for each infant?
Each infant is assessed by a multidisciplinary team to decide on the best course of action, which may range from observation to medication or closure, involving families in the process.
How can I find out more about the services at Nicklaus Children's Heart Institute?
For more information, please visit the Nicklaus Children's Heart Institute website or contact their office directly to learn more about their offerings in pediatric cardiac care.
